ATOPIC DERMATITIS| GALDERMA RD.06.SPR.118161 | PHASE III Status: RECRUITING Drug: CD14152 Timeline: TBD Detailed Description This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial for adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) andassociated pruritus whose disease is not adequately controlled by topical treatments. Inclusion Informed consent Male or female 12 years of age...Continue Reading